Abstract:Background: Recent study has proved the feasibility of transforming fibroblasts to excitable cells by means of gene engineering; dermal fibroblasts is the most abundant seed cells in organism. Objective: To investigate the effects of dermal fibroblasts transfected by both myogenic determination and connexin 43 genes on B-type natriuretic peptide (BNP) and myocardial infarction (MI) size by its function of transplantation in situ at the lesioned sites in acute MI rats. Design, time and setting: Randomized control experiments were carried out in the Cell Treatment Centre, East Hospital Affiliated to Tongji University and Experimental Animal Center of Shanghai University of Traditional Chinese Medicine (Shanghai, China) from June 2006 to March 2007. Materials: Sixty male Sprague-Dawley rats were randomly divided into four groups (n=15): normal control group, MI control group, normal transplantation group and MI transplantation group. Methods: MI model was established by ligating left coronary artery anterior descending branch in rats. Four weeks later, thoracotomy was performed to conduct myocardial cell transplantation in situ. Dermal fibroblasts were converted by both myogenic determination and connexin 43 genes, then were labeled with bromodeoxyuridine. The prepared cell suspension, 100 mL containing 1.0×106 cells, was transplanted into the juncture between MI area and unlesioned area. Ischemic myocardium from surrounding cardiac apex, interventricular septum and left ventricular anterior lateral wall was also transplanted with 100 μ L cell suspension, with the injector depth of 4 mm. In the control groups, DMEM cell liquid without cells were given. Main outcome measures: Before cell transplantation and 1 day, 1 week, 2 weeks, 4 weeks after cell transplantation, plasma BNP concentrations were detected. Heart rate, arterial blood pressure, left ventricular pressure, isovolumic contractive and diastolic function (left ventricular pressure maximal rate of rise and fall) were determined. MI size was measured in 4 weeks after cell transplantation using immunocytochemistry staining. Results: Immunocytochemistry results demonstrated the expression of bromodeoxyuridine in the myocardial scar area. Cell transplantation could significantly improve the hemodynamics in MI rats. Plasma BNP concentrations in the MI control group and the MI transplantation group were obviously higher than those in the normal control group and the normal transplantation group (P < 0.01). At 1 day, 1 week and 2 weeks after transplantation, there were no significant differences in the plasma BNP concentration between MI transplantation group and MI control group, but the concentration in the MI transplantation group was remarkably reduced 4 weeks later (P <0.01). MI size in the MI transplantation group was significantly smaller than those in the MI control group (P <0.01). Conclusion: In situ transplantation of dermal fibroblasts converted by both myogenic determination and connexin 43, can repair necrotic myocardium tissue and decrease the MI size.

The Research on the Feasibility of Using Cardiac Fibroblasts Could As Gene Target Cells

Biological Characteristics and Transgenic Study of Rat Cardiac Fibroblasts Culture in Vitro

Rat Fibroblasts Can Be Transfected by MyoD and Cx43 Gene to Produce Capable of Electrical Coupling Cell

Morphological changes of dermal fibroblasts of rat following transfection with MyoD cDNA in vitro

Abstract 210: Reprogramming Mouse Fibroblasts Into Cardiac Progenitor Cells Using Crispr Technique Targeting Endogenic Genes

[Effects of Myoblast Determining Gene and Connexin 43 Gene on Fibroblast Differentiation and Biological Function in Rats].

Improvement of Primary Culture of Cardiac Myocytes in Neonatal Rat

Comparison of Two Methods of Building Cardiac Fibroblasts Models Withβ3-AR Overexpression

Research expression in Cultured Rat Fibroblasts Transfected by MyoD and Cx43 Gene

Effect of myocardial transplantation after myogenic determination and connexin 43 genes transfected into dermal fibroblasts on B-type natriuretic peptide and infarcted size in rats with myocardial infarction

Targeting cardiac fibrosis with Chimeric Antigen Receptor-Engineered Cells

In Vivo Reprogramming of Mouse Fibroblasts into Cardiac Progenitor Cells for Myocardial Infarction Treatment

Lineage Reprogramming Of Fibroblasts Into Expandable Cardiac Progenitor Cells By Defined Small Molecules

Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.

Experimental studies on the differentiation of rat dermal fibroblasts into myoblast induced by myoD and Cx43 gene

Invitro Study of the Effects of Reprogramming Neonatal Rat Fibroblasts Transfected with TBX18 on Spontaneous Beating in Neonatal Rat Cardiomyocytes

Novel and Efficient Plasmid Transfection Protocols for Functional Analysis of Genetic Elements in Human Cardiac Fibroblasts

Targeting cardiac fibrosis with engineered T cells

Transplantation of 5-Azacytidine Treated Cardiac Fibroblasts Improves Cardiac Function of Infarct Hearts in Rats.

Regulation of cardiac fibroblasts reprogramming into cardiomyocyte‐like cells with a cocktail of small molecule compounds

ASSA13-03-40 the Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro